Loading...
•
Sep 30, 2023
Biolase Q3 2023 Earnings Report
Announced third quarter financial results, benefiting from strategic actions to streamline operations and gain greater operational efficiencies.
Key Takeaways
BIOLASE reported Q3 2023 financial results with a total revenue of $10.9 million. The company experienced a decrease in overall revenue compared to the previous year, but saw a 10% year-over-year increase in total consumable sales. Gross margin improved significantly to 34%, and the operating loss was reduced by 52% year over year.
Total revenue was $10.9 million, impacted by the current macro-environment.
Total consumable sales increased by 10% year-over-year.
Gross margin was 34%, a 1,400-basis expansion compared to the year-ago level.
Operating loss decreased by 52% year over year.
Biolase
Biolase
Biolase Revenue by Segment
Revenue by Segment
US Laser Revenue
CapyFin.comInternational Laser Revenue
CapyFin.com Forward Guidance
The Company currently expects full year 2023 revenue to be 1 to 3% higher than full year 2022 revenue. In addition, the Company expects net loss from operations for both the full year 2023 and for the fourth quarter of 2023 to be significantly improved compared to the comparable periods for the prior year.
Revenue & Expenses
Visualization of income flow from segment revenue to net income